Sonic Healthcare Limited (ASX: SHL) - ETF Exposure

Current share price for SHL : $18.810 0.02 (0.11%)⁺

Sonic Healthcare (SHL) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It is involved in provision of medical diagnostic services and the provision of administrative services and facilities to medical practitioners.

SHL General Information ⁺

ASX Code	SHL
Website	http://www.sonichealthcare.com
Industry/Sector	Health Care Services
Market Cap ($M)	9,296
SHL Share Price	$18.810
Day High	$18.860
Day Low	$18.670
Last Close	$18.790
SHL Share Price Movement	$0.02 ( 0.11% )

Prices as at 10:51, 28 Sep 2026

⁺Security prices are delayed by at least 20 minutes and are indicative only.

Already own an Australian ETF? You may already have meaningful exposure to SHL

As a significant Australian company by market capitalisation, SHL is held across 37 ETFs spanning strategies that include health care services exposure . Its weighting in those funds means performance can have an outsized influence - when SHL moves, funds like IHD, FAIR, VSO, ZYAU and MVW that hold it can move with it.

For more concentrated exposure, ETFs such as IHD (iShares S&P/ASX High Dividend Opportunities ETF) allocate about 2.1% to SHL , while the average exposure across all 37 ETFs that hold it is around 0.7% .

Top ETF holdings

iShares S&P/ASX High Dividend Opportunities ETF (IHD) ~ 2.1%
BetaShares Australian Sustainability Leaders ETF (FAIR) ~ 2.1%
Vanguard MSCI Australian Small Companies Index ETF (VSO) ~ 1.6%
Global X S&P/ASX 200 High Dividend ETF (ZYAU) ~ 1.3%
VanEck Australian Equal Weight ETF (MVW) ~ 1.3%

Last updated: ETF data and holdings as at 27 September 2026

Own SHL directly or through an ETF?

How does holding Sonic Healthcare Limited (SHL) shares directly compare to ETFs that include it?

	SHL Direct	IHD ASX	FAIR ASX	VSO ASX	ZYAU ASX	MVW ASX
Holdings	1 company	56 holdings	83 holdings	203 holdings	59 holdings	76 holdings
SHL Weight	100%	2.1%	2.1%	1.6%	1.3%	1.3%
Diversification	Single Stock	Broad	Broad	Broad	Broad	Broad
Annual Cost	Brokerage only	0.23% p.a.	0.49% p.a.	0.3% p.a.	0.24% p.a.	0.35% p.a.
Approx. Yield	5.2%	4.14%	3.2%	4.83%	4.31%	3.46%
Star Ratings	-

Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not SHL's direct yield. Annual cost uses each ETF's MER.

SHL Exposure on $10,000 investment

How a $10,000 investment in Sonic Healthcare Limited (SHL) one week ago compares with ETFs that hold it.

Security	Investment type	Current price	7-day price movement	Dollar change	Value today
Sonic Healthcare Limited (SHL)	Direct share	$18.810	-2.23%	-$223	$9,777
iShares S&P/ASX High Dividend Opportunities ETF (IHD)	Equity - Australia Strategy	$16.650	-0.95%	-$95	$9,905
BetaShares Australian Sustainability Leaders ETF (FAIR)	Equity - Australia Strategy	$18.070	-1.58%	-$158	$9,842
Vanguard MSCI Australian Small Companies Index ETF (VSO)	Equity - Australia Small/Mid Cap	$72.300	-1.24%	-$124	$9,876
Global X S&P/ASX 200 High Dividend ETF (ZYAU)	Equity - Australia Strategy	$10.130	-0.98%	-$98	$9,902
VanEck Australian Equal Weight ETF (MVW)	Equity - Australia	$37.830	-0.76%	-$76	$9,924

Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.

Sonic Healthcare Limited (SHL) ETFs

37 ETFs hold Sonic Healthcare Limited (SHL).

ETF	SHL Weight	MER	Yield
iShares S&P/ASX High Dividend Opportunities ETF (IHD)	2.1%	0.23%	4.14%
BetaShares Australian Sustainability Leaders ETF (FAIR)	2.1%	0.49%	3.2%
Vanguard MSCI Australian Small Companies Index ETF (VSO)	1.6%	0.3%	4.83%
Global X S&P/ASX 200 High Dividend ETF (ZYAU)	1.3%	0.24%	4.31%
VanEck Australian Equal Weight ETF (MVW)	1.3%	0.35%	3.46%
Global X Australia ex Financials & Resources ETF (OZXX)	1.2%	0.25%	5.28%
VanEck MSCI Australian Sustainable Equity ETF (GRNV)	1.2%	0.35%	3.69%
State Street SDPR MSCI AUS Select High Dividend Yield ETF (SYI)	1.2%	0.2%	8.44%
Dimensional Australian Value Trust - Active ETF (DAVA)	1.1%	0.34%	6.6%
ishares Edge MSCI Australia Multifactor ETF (AUMF)	1.1%	0.3%	2.85%

View all 37 ETFs

Sonic Healthcare Limited (SHL) Upcoming Dividends & Yields

Distribution Type	Dividend	Franking	Ex-dividend date	Payment date	Current Price⁺	Price 7D Avg	Dividend Yield
HFResult	63¢	60%	2 Sep 2026	17 Sep 2026	-	-	-
Result	45¢	60%	4 Mar 2026	19 Mar 2026	-	-	-
HFResult	63¢	35%	3 Sep 2025	18 Sep 2025	-	-	-

See all dividends from Sonic Healthcare Limited (SHL) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Sonic Healthcare Limited (SHL) price-sensitive announcements

SHL - Financial and Operational Review - Year Ended 30 June 2026

Sonic Healthcare Limited reported a successful financial year ended 30 June 2026, with a 1

Sonic Healthcare Limited (SHL)
20 Aug 2026 | 9:23 AM

SHL - Media Release - Full Year Results to 30 June 2026

Sonic Healthcare Limited reported a robust financial performance for the fiscal year endin

Sonic Healthcare Limited (SHL)
20 Aug 2026 | 9:22 AM

SHL - Preliminary Final Report FY2026

Sonic Healthcare Limited's Preliminary Final Report for the financial year ending June 30,

Sonic Healthcare Limited (SHL)
20 Aug 2026 | 9:17 AM

SHL - CEO Presentation Half Year Results to 31 December 2025

Sonic Healthcare Limited reported its half-year results for the period ending 31 December

Sonic Healthcare Limited (SHL)
19 Feb 2026 | 8:50 AM

Sonic Healthcare Limited (SHL) Recent ASX Announcements

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
Sonic Healthcare Limited (SHL) ORDINARY FULLY PAID	Health Care	$9,297	Change of Registry Address Notification	25 Sep 2026 9:34AM	$18.910	$18.810	fallen by 0.53%
Sonic Healthcare Limited (SHL) ORDINARY FULLY PAID	Health Care	$9,297	Appendix 4G	24 Sep 2026 5:37PM	$18.910	$18.810	fallen by 0.53%
Sonic Healthcare Limited (SHL) ORDINARY FULLY PAID	Health Care	$9,297	Annual Report to shareholders	24 Sep 2026 5:32PM	$18.910	$18.810	fallen by 0.53%
Sonic Healthcare Limited (SHL) ORDINARY FULLY PAID	Health Care	$9,297	Notification regarding unquoted securities - SHL	24 Sep 2026 5:27PM	$18.910	$18.810	fallen by 0.53%
Sonic Healthcare Limited (SHL) ORDINARY FULLY PAID	Health Care	$9,297	Notification of cessation of securities - SHL	24 Sep 2026 5:18PM	$18.910	$18.810	fallen by 0.53%
Sonic Healthcare Limited (SHL) ORDINARY FULLY PAID	Health Care	$9,297	Notification of cessation of securities - SHL	24 Sep 2026 5:18PM	$18.910	$18.810	fallen by 0.53%

SHL Financial Summary

Year to Jun	NPAT	EPS	EPS chg (%)	PER	DPS	Yield (%)	Franking (%)
2026F	$601.94	$119.00	18.50%	23.88	109.00	3.84%	30.0%
2025F	$507.92	$100.41	-1.70%	28.30	108.00	3.80%	30.0%
2024A	$487.02	$102.10	-29.60%	29.37	106.00	3.54%	0.0%

SHL Peer Comparison

Company	Mkt Cap	EPS Growth (%)			P/E (%)			Dividend Yield (%)
Company	Mkt Cap	2024 A	2025 F	2026 F	2024 A	2025 F	2026 F	2024 A	2025 F	2026 F
Australian Clinical Labs Limited (ACL)	$526M	0.0442	-0.0111	0.0428	14.9127	15.0802	14.4615	4.61%	4.61%	4.43%
Integral Diagnostics Limited (IDX)	$839M	0.7037	0.0000	0.1877	17.2414	17.2414	14.5161	4.13%	3.33%	3.78%
Sonic Healthcare Limited (SHL)	$9,346M	0.0839	-0.0157	0.1040	16.3511	16.6125	15.0473	5.71%	5.55%	5.84%

SHL Market Comparison

	Earnings	P/E Ratio	P/B Ratio	P/E Growth
Company	0.55	14.20	1.11	0.00
Market	0.58	15.40	1.62	1.22
Sector	0.62	20.80	1.80	2.50

SHL Directors

Name	Position	Start Date
Mr Christopher David Wilks	Chief Financial Officer, Finance Director	5 Dec 1989
Mr Neville Mitchell	Non-Executive Director	29 Sep 2017
Professor Suzanne Crowe	Non-Executive Director	6 Apr 2020
Professor Christine Constance Bennett	Non-Executive Director	26 Sep 2022
Ms Kathryn (Kate) Dianne Spargo	Non-Executive Director	1 Jul 2010
Ms Nicola Wakefield Evans	Non-Executive Director	10 Feb 2025
Dr Katharine Giles	Non-Executive Director	26 Sep 2022
Mr James Pacey Newcombe	Non-Executive Director	20 Nov 2025
Mr Mark Raymond Compton	Non-Executive Director, Non-Executive Chairman	7 Oct 2014

Sonic Healthcare Limited (SHL) Changes in Directors' Interest & Trades

Date of change	Director	Buy/Sell	Security Type	Qty	Trade Price	Value
16 Oct 2025	WAKEFIELD EVANS, Nicola	Buy	Indirect Shares	2,500	$21.780	$54,450.000
15 Oct 2025	GILES, Katharine	Buy	Indirect Shares	1,000	$21.169	$21,169.200
3 Oct 2025	GILES, Katharine	Buy	Indirect Shares	1,000	$21.720	$21,720.000

See all changes in directors' interest & trades for Sonic Healthcare Limited (SHL) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

SHL Management

Name	Position
Paul Joseph Alexander	Company Secretary,Deputy Chief Financial Officer

SHL Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Sonic Healthcare Limited (SHL). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding	Name
35,419,922 (7.17%)	State Street Corporation and subsidiaries
34,297,014 (6.94%)	BlackRock Group
28,857,614 (5.84%)	The Vanguard Group,Inc

SHL Calendar of Events

Date	Event
23 September 2027	Report (Annual)
19 August 2027	Report (Prelim)
18 February 2027	Report (Interim)
19 November 2026	AGM

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.

What our members say about us